Top investors important for Luxembourg Health ecosystem with the biggest sum of funding rounds in industry over the recent years

Intro

Luxembourg’s General Development Cooperation Strategy: The Road to 2030 highlights health as a key area for eradicating poverty. Luxembourg has pledged to improve access to safe and affordable health care with stronger domestic health systems.
Managed by Luxinnovation, the Luxembourg HealthTech Cluster aims is to promote the development of new and existing companies through innovation, thereby contributing to economic growth and job creation. The cluster also strives to capitalise on the country’s advanced digital expertise in order to stimulate the development and commercialisation of health technologies.
Also managed by Luxinnovation and initiated by the Luxembourg Ministry of Economy, Fit 4 Start acceleration programme, dedicated to high potential start-ups, included companies operating within HealthTech to its programme in 2018.
The government’s firm commitment to establishing Luxembourg as an attractive destination for health sciences research and innovation is backed by substantial public investment and a supportive business environment. The new incubator in the field of health technologies is expected to open in spring 2021 and become home to up to 10 companies of start-up and spin-off type.
From 2020 to 2022, Luxembourg is co-chairing the Special Programme for Research and Training in Tropical Diseases, a partnership hosted by World Health Organization (WHO). WHO and Luxembourg work together in key health areas including universal health coverage; reproductive, maternal, newborn, child and adolescent health; health emergencies; polio eradication; and tropical disease research.

The top 50 investors according to the total money raised in the funding rounds. These are VC funds and corporate investors in Western Europe that have invested over the last 3 years. They are actively investing in Health Care and Health Diagnostics industries.

Amount of money raised in Health Care and Health Diagnostics funding rounds is $16.9B, which is 8.6% of the total amount of money raised in rounds in Western Europe over the last 3 years.

Top investors important for Luxembourg Health ecosystem with the biggest sum of funding rounds in industry over the recent years
data provided by Unicorn Nest

Key takeaways

• Funds Geography – The most common countries among top VCs are France and Germany. They host 16 VCs each. There are also funds from Switzerland and Belgium. The most common city is Paris which is home to 14 funds. There are also funds from Munich, Basel and Berlin. VCs in the sample usually invest in France and Germany. They also invest in The United States and Belgium. For the majority of the funds, the country of the funds’ establishment and the country of their most frequent investments coincide.
• Industry Focus – The funds’ most common field for investments is Finance. They also invest in Banking, Medical Service and Bio & Nano Technology.
• Important Years – The oldest fund in the sample was founded in 1880 and the newest one in 2013. In 1997 the most amount of funds were founded. VCs in the sample made the most deals in the period from 2004 to 2020. For some funds, 2017 was the year with the most amount of deals.
• Investments – Usually VCs take part in 2 – 6 funding rounds per year, sometimes in 7 – 12, 2 or in 13 – 24. The minimum number of funding rounds for VCs in the sample is 2, the maximum is 482. Average number of funding rounds is 94.4 while median is 76.0. Minimum amount of lead investments for funds is 0 and maximum is 166. Average amount of lead investments is 31.8 while median is 18.5. The most common amount of lead investments is 4. Index of difference in percentage points of lead investments from the average is between -46.0 and 29.0 for funds in the sample. The average value for this difference is -3.49 and the median is -3.17. It means that these funds act as lead investors less often than other funds. The most common value is -21.0.
• Typical Rounds – The most common investment stage for funds in the sample is Early stage. Late, Seed and Private Equity stages are less common. Funds participate in rounds with 3 – 4 or 4 – 5 investors more often than in rounds with 2 – 3 or 5 – 6 investors. The most common round size for VCs in the sample is less than 100 thousands. Less common ranges are 100 thousands – 1 million, 1 – 5 million and 10 – 50 million. A Funds’ average multiplicator for portfolio companies at the last known valuation is 0.0 at minimum and 1.19 at maximum. Average value for this multiplicator is 0.09 and median is 0.02. The most common multiplicator value is 0.0.